These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 34490046)

  • 1. Identification of a Novel Glycolysis-Related LncRNA Signature for Predicting Overall Survival in Patients With Bladder Cancer.
    Zheng Z; Lai C; Li W; Zhang C; Ma K; Yao Y
    Front Genet; 2021; 12():720421. PubMed ID: 34490046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and validation of a prognostic immune-related lncRNA signature in bladder cancer.
    Zhao K; Zhang Q; Zeng T; Zhang J; Song N; Wang Z
    Transl Androl Urol; 2021 Mar; 10(3):1229-1240. PubMed ID: 33850758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and validation of a glycolysis-related lncRNA signature for prognosis prediction in Stomach Adenocarcinoma.
    Liao T; Lu Y; Li W; Wang K; Zhang Y; Luo Z; Ju Y; Ouyang M
    Front Genet; 2022; 13():794621. PubMed ID: 36313430
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of necroptosis-related long non-coding RNAs prognostic signature and the crucial lncRNA in bladder cancer.
    Sun YF; Chen L; Xia QJ; Wang TH
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10217-10234. PubMed ID: 37269345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A robust signature of immune-related long non-coding RNA to predict the prognosis of bladder cancer.
    Lai C; Wu Z; Li Z; Yu H; Li K; Tang Z; Liu C; Xu K
    Cancer Med; 2021 Sep; 10(18):6534-6545. PubMed ID: 34374227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance and identification of basement membrane-associated lncRNA in bladder cancer.
    Feng L; Yang J; Zhang W; Wang X; Li L; Peng M; Luo P
    Front Oncol; 2022; 12():994703. PubMed ID: 36300088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Glycolysis-Related Long Noncoding RNA Signature for Predicting Overall Survival in Gastric Cancer.
    Zeng J; Li M; Dai K; Zuo B; Guo J; Zang L
    Pathol Oncol Res; 2022; 28():1610643. PubMed ID: 36419649
    [No Abstract]   [Full Text] [Related]  

  • 8. A novel necroptosis-related lncRNA based signature predicts prognosis and response to treatment in cervical cancer.
    Du X; Pu X; Wang X; Zhang Y; Jiang T; Ge Y; Zhu H
    Front Genet; 2022; 13():938250. PubMed ID: 36561319
    [No Abstract]   [Full Text] [Related]  

  • 9. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
    Peng Y; Wang H; Huang Q; Wu J; Zhang M
    J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma.
    Yu J; Mao W; Sun S; Hu Q; Wang C; Xu Z; Liu R; Chen S; Xu B; Chen M
    Front Oncol; 2021; 11():663263. PubMed ID: 34123820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An innovative model based on N7-methylguanosine-related lncRNAs for forecasting prognosis and tumor immune landscape in bladder cancer.
    Ren L; Yang X; Liu J; Wang W; Liu Z; Lin Q; Huang B; Pan J; Mao X
    Cancer Cell Int; 2023 May; 23(1):85. PubMed ID: 37158958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a novel five-lncRNA prognostic signature for predicting overall survival in elderly patients with breast cancer.
    Luo Y; Zhang Y; Wu YX; Li HB; Shen D; Che YQ
    J Clin Lab Anal; 2022 Jan; 36(1):e24172. PubMed ID: 34894405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel necroptosis-related lncRNA signature for predicting prognosis and immune response of colon cancer.
    Luo J; Peng J; Xiao W; Huang S; Cao Y; Wang T; Wang X
    Front Genet; 2022; 13():984696. PubMed ID: 36092933
    [No Abstract]   [Full Text] [Related]  

  • 15. Construction and Validation of a Novel Ferroptosis-Related lncRNA Signature to Predict Prognosis in Colorectal Cancer Patients.
    Zhang W; Fang D; Li S; Bao X; Jiang L; Sun X
    Front Genet; 2021; 12():709329. PubMed ID: 34777458
    [No Abstract]   [Full Text] [Related]  

  • 16. Construction of a prognostic model of colon cancer patients based on metabolism-related lncRNAs.
    Li C; Liu Q; Song Y; Wang W; Zhang X
    Front Oncol; 2022; 12():944476. PubMed ID: 36248984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Signature Development on the Basis of Macrophage Phagocytosis-Mediated Oxidative Phosphorylation in Bladder Cancer.
    Qu G; Xu Y; Lu Z; Nie H; Tang C; Hou J; Wen X
    Oxid Med Cell Longev; 2022; 2022():4754935. PubMed ID: 36211821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of a novel glycolysis-related gene expression signature for gastrointestinal cancer in the Asian population.
    Xia R; Tang H; Shen J; Xu S; Liang Y; Zhang Y; Gong X; Min Y; Zhang D; Tao C; Wang S; Zhang Y; Yang J; Wang C
    Cancer Cell Int; 2021 Mar; 21(1):154. PubMed ID: 33663535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy-related long non-coding RNA prognostic model predicts prognosis and survival of melanoma patients.
    Qiu Y; Wang HT; Zheng XF; Huang X; Meng JZ; Huang JP; Wen ZP; Yao J
    World J Clin Cases; 2022 Apr; 10(11):3334-3351. PubMed ID: 35611195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma.
    Bai Y; Lin H; Chen J; Wu Y; Yu S
    Front Mol Biosci; 2021; 8():645084. PubMed ID: 33968985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.